ID	Species	ncRNA	ncRNA type	Environmental factor (EF)	Phenotype	Sample	Condition of EF	Evidence	PubMed ID
1	Human	chr13:50054355-50057699	circRNA	adriamycin (ADR)	acute myeloid leukemia (AML)	HL-60 cells	adriamycin (ADR) treatment	downregulated	31818729
2	Human	chr13:50054355-50057699+	circRNA	adriamycin (ADR)	acute myeloid leukemia (AML)	HL-60 cells	adriamycin (ADR) treatment	downregulated	31818729
3	Human	chr14:101402109-101464448+	circRNA	gemcitabine (GEM)	pancreatic cancer (PC)	PANC-1 cells	gemcitabine (GEM) treatment	chr14:101402109- 101464448+ was found significantly upregulated in non-responsive group.	29922161
4	Human	chr18:21644104-21649235	circRNA	adriamycin (ADR)	acute myeloid leukemia (AML)	HL-60 cells	adriamycin (ADR) treatment	downregulated	31818729
5	Human	chr18:21644104-21649235+	circRNA	adriamycin (ADR)	acute myeloid leukemia (AML)	HL-60 cells	adriamycin (ADR) treatment	downregulated	31818729
6	Human	chr2:15629018-15651474	circRNA	adriamycin (ADR)	acute myeloid leukemia (AML)	HL-60 cells	adriamycin (ADR) treatment	upregulated	31818729
7	Human	chr4:52729603-52780244+	circRNA	gemcitabine (GEM)	pancreatic cancer (PC)	PANC-1 cells	gemcitabine (GEM) treatment	chr4:52729603-52780244+ was found significantly upregulated in non-responsive group.	29922161
8	Human	chr7:2330794-22357656	circRNA	adriamycin (ADR)	acute myeloid leukemia (AML)	HL-60 cells	adriamycin (ADR) treatment	upregulated	31818729
9	Human	chr7:2330794-22357656-	circRNA	adriamycin (ADR)	acute myeloid leukemia (AML)	HL-60 cells	adriamycin (ADR) treatment	upregulated	31818729
10	Human	circABCB10	circRNA	paclitaxel (PTX)	breast cancer	BC tissues; MCF-7 cells MDA-MB-231	Paclitaxel (PTX) treatment	upregulated	32273769
11	Human	circABCB10	circRNA	cisplatin (DDP)	lung cancer	A549 cells; NCl H292 cells	cisplatin treatment	downregulated	31931771
12	Human	circACTR2	circRNA	glucose	diabetic nephropathy (DN)	HK-2 cells	glucose treatment	"CircACTR2 regulates high glucose-induced pyroptosis, inflammation and fibrosis in proximal tubular cells."	32115515
13	Human	circADAM9	circRNA	high glucose (HG)	dysfunction of endothelial progenitor cells (EPCs)	human endothelial progenitor cells (EPCs)	high glucose (HG) treatment	Circ-ADAM9 targeting PTEN and ATG7 promotes autophagy and apoptosis of diabetic endothelial progenitor cells by sponging mir-20a-5p.	32661238
14	Human	circANKRD11	circRNA	cigarette smoke extract (CSE)	chronic obstructive pulmonary disease (COPD)	Human pulmonary microvascular endothelial cells HPMECs	cigarette smoke extract (CSE) treatment	"CircANKRD11 and BRD4 expression were increased, whereas miR-145-5p expression was decreased in the lung tissues of smokers with or without COPD and CSE-induced HPMECs"	33833509
15	Human	circANKRD36	circRNA	lipopolysaccharide (LPS)	bedsore	HaCaT cells	lipopolysaccharide (LPS) treatment	upregulated	31692058
16	Human	circANKRD36	circRNA	lipopolysaccharide (LPS)	inflammatory injury	HaCaT cells	lipopolysaccharide (LPS) treatment	circANKRD36 remitted cell inflammatory damage upregulating miR-15/MyD88 via the NF-¦ÊB pathway in HaCaT cells.	31692058
17	Human	circANKRD36	circRNA	IL-1¦Â	osteoarthritis (OA)	human chondrocytes	IL-1¦Â treatment	circANKRD36 sponge miR-599 to up-regulate the expression of Casz1 and thus prevent apoptosis and inflammation in OA.	33205602
18	Human	circANKRD36	circRNA	lipopolysaccharide (LPS)	pneumonia	MRC-5 cells	lipopolysaccharide (LPS) treatment	LPS irritation raised the level of circANKRD36 in MRC-5 cells.	31793082
19	Human	circANKRD36	circRNA	sepsis	pneumonia	human embryonic lung fibroblast MRC-5 cell	human embryonic lung fibroblast MRC-5 cell injury irritated by lipopolysaccharide (LPS) treatment	"LPS aroused a decrease in viability, increases in apoptosis, ROS, and IL-6, IL-8, and TNF-¦Á, along with circANKRD36, and activation of NF-¦ÊB pathway Silencing circANKRD36 weakened the above-mentioned influences of LPS"	31793082
20	Human	circANRIL	circRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	human brain microvascular endothelial cells (HBMECs)	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	"The expression of circ_ANRIL in OGD/R-induced human brain microvascular endothelial cells (HBMECs) was significantly upregulated, while that of miR-622 was significantly downregulated"	32616043
21	Human	circANRIL	circRNA	lipopolysaccharide (LPS)	inflammation	HK-2 cells	lipopolysaccharides (LPS) treatment	upregulated	31432701
22	Human	circARF3	circRNA	tumor necrosis factor alpha (TNF-¦Á) 	encephalitis	SH-SY5Y cells	tumor necrosis factor alpha (TNF-¦Á) treatment	TNF-¦Á inducement also markedly reduced circARF3 expression.	32329660
23	Human	circARL3	circRNA	hepatitis B virus (HBV)	hepatocellular carcinoma (HCC)	HCC tissues	hepatitis B virus (HBV) infection	upregulated	33372396
24	Human	circATP2B4	circRNA	hypoxia	pulmonary arterial hypertension (PAH)	pulmonary arterial smooth muscle cells (PASMCs)	hypoxia treatment	CircATP2B4 potentiated hypoxia-induced proliferation and migration of PASMCs through the miR-223/ATR axis.	32926932
25	Human	circAtp9b	circRNA	lipopolysaccharide (LPS)	inflammation	MRC-5 cells	lipopolysaccharide (LPS) treatment	LPS triggered adverse inflammation response by elevating the biogenesis of circAtp9b which caused a repressive role in miR-27a expression.	31735661
26	Human	circAtp9b	circRNA	lipopolysaccharide (LPS)	pneumonia	MRC-5 cells	lipopolysaccharide (LPS) treatment	LPS triggered adverse inflammation response by elevating the biogenesis of circAtp9b which caused a repressive role in miR-27a expression.	31735661
27	Human	circBCRC4	circRNA	gambogic acid (GA)	bladder cancer	T24T and UMUC3 cells	Gallic acid (GA) treatment	upregulated	29270748
28	Human	circBPTF	circRNA	high glucose (HG)	endothelial dysfunction	human umbilical vein endothelial cells (HUVECs)	high glucose (HG) treatment	CircBPTF knockdown protected against HG-induced inflammatory injuries and oxidative stress by mediating the miR-384/LIN28B axis in HUVECs.	32524321
29	Human	circCamk4	circRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	SH-SY5Y Cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	circ-camk4 (hsa-circ-camk4) are elevated in SH-SY5Y cells exposed to OGD/R treatment	32332879
30	Human	circCCDC66	circRNA	oxaliplatin	colorectal cancer (CRC)	HCT116 cells; HT-29 cells	oxaliplatin (OXA) treatment	circCCDC66 is elevated in colorectal cancer cells with resistance to oxaliplatin	32187976
31	Human	circCCDC66	circRNA	oxaliplatin	colorectal cancer (CRC)	HCT116 cells; HT-29 cells	oxaliplatin treatment	circCCDC66 is elevated in colorectal cancer cells with resistance to oxaliplatin	32187976
32	Human	circCDK8	circRNA	CoCl2	periodontitis	human Periodontal ligament stem cells (PDLSCs)	CoCl2 treatment	upregulated	32978798
33	Human	circCDR1as	circRNA	cisplatin (DDP)	bladder cancer	"human bladder cancer cell lines TCCSUP, 5367, T24 and EJ"	cisplatin treatment	Cdr1as induced the apoptosis and enhanced the cisplatin chemosensitivity of bladder cancer cells both in vitro and in vivo.	31131537
34	Human	circCDR1as	circRNA	3-methyladenine (3-MA)	oral squamous cell carcinoma (OSCC)	Tca-8113 cells	3-Methyladenine (3-MA) treatment	upregulated	31582727
35	Human	circCDR1as	circRNA	hypoxia	oral squamous cell carcinoma (OSCC)	Tca-8113 cells	hypoxia induce	upregulated	31582727
36	Human	circCDR1as	circRNA	rapamycin	oral squamous cell carcinoma (OSCC)	Tca-8113 cells	rapamycin treatment	upregulated	31582727
37	Human	circCDR1as	circRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	upregulated	32018039
38	Human	circCDR1as	circRNA	cisplatin (DDP)	ovarian cancer (OC)	Human ovarian cancer cell lines (A2780 and SKOV-3)	cisplatin treatment	there was a decreasing trend in Cdr1as levels from normal ovarian tissues to cisplatinsensitive ovarian cancer tissues and then to cisplatin-resistant ovarian cancer tissues. Cdr1as Enhances the Cisplatin Chemosensitivity of Ovarian Cancer In Vitro.	31479922
39	Human	circCDR1as	circRNA	lipopolysaccharide (LPS)	periodontitis	Human periodontal ligament cells (PDLCs)	lipopolysaccharide (LPS) treatment	"CDR1as was significantly downregulated in LPS-treated PDLSCs compared to untreated cells, as well as in normal periodontal ligament tissues compared to periodontitis tissues."	31582895
40	Human	circCDR1as	circRNA	hypoxia	pulmonary hypertension (PH)	Human pulmonary artery smooth muscle cell (HPASMC)	hypoxia treatment	CDR1as/miR-7-5p/CNN3 and CAMK2D regulatory axis mediates HPASMC osteoblastic differentiation and calcification induced by hypoxia.	33230455
41	Human	circCDR1as	circRNA	silica	silicosis	HBE cells; A549 cells	silica treatment	The increase of circRNA CDR1as was observed after treatment of silica	30202956
42	Human	circCHFR	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	human vascular smooth muscle cells (VSMCs)	oxidized low-density lipoprotein (ox-LDL) treatment	Circ_CHFR contributed to the progression of AS through the miR-214-3p/Wnt3/¦Â-catenin signals.	32271446
43	Human	circChr19	circRNA	ebola virus (EBOV)	Ebola virus (EBOV) therapy	293T cells	EBOV treatment	upregulated	29209594
44	Human	circCIDN	circRNA	compression force (CF)	intervertebral disc degeneration (IDD)	nucleus pulposus (NP) cells	compression treatment	CircRNA-CIDN was significantly downregulated in compression-treated human NP cells.	32114390
45	Human	circCILinc02	circRNA	methylene blue (MB)	osteoarthritis (OA)	chondrocytes	methylene blue treatment	CILinc02 was increased in primary cells of OA but was reduced in primary OA cells treated with MB.	30548658
46	Human	circCircNFIX	circRNA	temozolomide (TMZ)	glioblastoma multiforme (GBM)	LN229 cells; U251 cells	temozolomide (TMZ) treatment	Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma	32194140
47	Human	circCLASP2	circRNA	high glucose (HG)	diabetic-associated vascular injury	Human umbilical vein endothelial cells (HUVECs)	high-glucose (HG) treatment	High glucose (HG) exposure downregulated the expression of circ_CLASP2 in HUVECs	33776760
48	Human	circCOG8	circRNA	mechanical stress	intervertebral disc degeneration (IDD)	NP cells	mechanical stress treatment	circCOG8 expression was obviously downregulated by the mechanical stress in disk NP cells.	33195225
49	Human	circCOL1A2	circRNA	high glucose (HG)	diabetic retinopathy (DR)	human retinal microvascular endothelial cells (hRMECs)	high glucose (HG) treatment	Circular RNA COL1A2 promotes angiogenesis via regulating miR-29b/VEGF axis in diabetic retinopathy.	32497630
50	Human	circDHRS3	circRNA	IL-1¦Â	osteoarthritis (OA)	human chondrocytes	IL-1¦Â treatment	Circ_DHRS3 expression was elevated in OA cartilage tissues and IL-1¦Â-treated chondrocytes.	33360372
51	Human	circDHRS3	circRNA	IL-1¦Â	osteoarthritis (OA)	chondrocytes	IL-1¦Â treatment	Circ_DHRS3 expression was elevated in OA cartilage tissues and IL-1¦Â-treated chondrocytes.	33360372
52	Human	circDLGAP4	circRNA	hypoxia	ischemia/reperfusion (I/R) injury	Human umbilical vein endothelial cells (HUVECs)	hypoxia induce	downregulated	31607223
53	Human	circDLGAP4	circRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	Human neuroblastoma cell line SH-SY5Y	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	circDLGAP4 expression was decreased in MPTP-induced PD mouse model and MPP+-induced PD cell models.	31761328
54	Human	circDLGAP4	circRNA	1-methyl-4-phenylpyridinium (MPP+)	parkinson's disease (PD)	SH-SY5Y Cells	1-methyl-4-phenylpyridinium (MPP+) treatment	circDLGAP4 expression was decreased in MPP+-induced PD cell models.	31761328
55	Human	circDNMT3B	circRNA	high glucose (HG)	diabetic retinopathy (DR)	human retinal microvascular endothelial cells (HRMECs)	High Glucose (HG) treatment	downregulated	31636010
56	Human	circDONSON	circRNA	cisplatin (DDP)	gastric cancer (GC)	AGS cells; HGC cells	cisplatin treatment	circDONSON promoted cisplatin resistance in gastric cancer cells by regulating miR-802/BMI1 axis.	32581651
57	Human	circDROSHA	circRNA	magnesium-free extracellular fluid	temporal lobe epilepsy (TLE)	SK-N-SH cells; IMR-32 cells	magnesium-free extracellular solution	downregulated	33370579
58	Human	circDYM	circRNA	repetitive transcranial magnetic stimulation (rTMS)	breast cancer	plasma	repetitive transcranial magnetic stimulation (rTMS) treatment	circDYM expression was upregulated after rTMS treatment	32663980
59	Human	circERCC2	circRNA	tert-butyl hydroperoxide (TBHP)	intervertebral disc degeneration (IDD)	nucleus pulposus cells (NPCs)	tert-butyl hydroperoxide (TBHP) treatment	downregulated	31582722
60	Human	circFAM172A	circRNA	5-fluorouracil (5-Fu)	osteosarcoma (OS)	MG63 cells	5-fluorouracil (5-FU) treatment	upregulated	33308021
61	Human	circFANCA	circRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	Human renal proximal tubular cell line HK-2	lipopolysaccharide (LPS) treatment	Circ-FANCA was upregulated in septic AKI serum specimens and LPS-treated HK2 cells.	33468219
62	Human	circFBXW7	circRNA	oxaliplatin	colorectal cancer (CRC)	SW480 cells; HCT116 cells; colorectal cancer (CRC) tissues	oxaliplatin treatment	circ-FBXW7 was measured and results showed circ-FBXW7 was lower in oxaliplatin-resistant CRC patients and resistant CRC cells than that in controls	33147048
63	Human	circFLNA	circRNA	fucoidan	oral squamous cell carcinoma (OSCC)	SCC15 cells; SCC25 cells	fucoidan treatment	upregulated	31495936
64	Human	circFLNA	circRNA	fucoidan	oral squamous cell carcinoma (OSCC)	Human tongue squamous carcinoma cells (SCC15 and SCC25)	fucoidan treatment	upregulated	31495936
65	Human	circFN1	circRNA	cisplatin (DDP)	gastric cancer (GC)	SGC7901 cells; BGC823C cells	cisplatin treatment	circFN1 enhances cisplatin resistance in gastric cancer via sponging miR-182-5p.	31898357
66	Human	circFOXM1	circRNA	naringenin	lung cancer	A549 cells; PC9 cells	naringenin treatment	Naringenin hindered cell metastasis in vitro and tumor growth in vivo by reducing circFOXM1 and SPAG5 expression and inducing the expression of miR-3619-5p in lung cancer.	32598178
67	Human	circGCN1L1	circRNA	tumor necrosis factor alpha (TNF-¦Á) 	temporomandibular joint osteoarthritis	synoviocyte	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	32332704
68	Human	circGRN	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	human vascular smooth muscle cells (HVSMCs)	oxidized low-density lipoprotein (ox-LDL) treatment	"In this study, we found that circ_GRN was elevated in the serum of AS and oxidized low-density lipoprotein (ox-LDL)-induced HVSMCs."	33818550
69	Human	circHDAC9	circRNA	amyloid-¦Â (A¦Â) 42	Alzheimer's disease (AD)	HN cells	amyloid-¦Â (A¦Â) 42 treatment	Berberine attenuates A¦Â42-induced neuronal damage through regulating circHDAC9/miR-142-5p axis in human neuronal cells	32251633
70	Human	circHECTD1	circRNA	silicon dioxide (SiO2)	macrophage activation	Primary cultures of alveolar macrophages from healthy donors and patients	silicon dioxide (SiO2) treatment	downregulated	29290828
71	Human	circHECTD1	circRNA	SiO2	silicosis	HPF-a cells	SiO2 treatment	"After exposure to SiO2, the circHECTD1 level was decreased, which was associated with an increase in HECTD1 in HPF-a cells SiO2-induced autophagy was reversed by either circHECTD1 overexpression or HECTD1 knockdown in HPF-a cells"	31832126
72	Human	circHIAT1	circRNA	baicalin (BAI)	cervical cancer (CC)	Human CC cell lines (HeLa and SiHa)	baicalin (BAI) treatment	upregulated	33603395
73	Human	circHIPK3	circRNA	platelet-derived growth factor (PDGF)	airway remodeling	airway smooth muscle cells (ASMCs)	platelet-derived growth factor (PDGF) treatment	circHIPK3 was significantly upregulated in platelet-derived growth factor (PDGF) induced ASMCs	32450169
74	Human	circHIPK3	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	human umbilical vein endothelial cells (HUVECs)	oxidized low-density lipoprotein (ox-LDL) treatment	The expression of circHIPK3 was downregulated in ox-LDL treated HUVECs.	33378035
75	Human	circHIPK3	circRNA	H2O2	cytotoxicity	OB-6 cells	Hydrogen peroxide (H2O2) treatment	downregulated	31955154
76	Human	circHIPK3	circRNA	oleic acid (OA)	diabetes-associated metabolic disorders	HepG2 cells	oleate treatment	circHIPK3 contributes to hyperglycemia and insulin resistance by sponging miR-192-5p and up-regulating FOXO1.	31875589
77	Human	circHIPK3	circRNA	high glucose (HG)	diabetic nephropathy (DN)	HK-2 cells	high glucose (HG) treatment	Expression level of circHIPK3 in HK-2 cells was remarkably decreased after the treatment of HG.	33628038
78	Human	circHIPK3	circRNA	temozolomide (TMZ)	glioblastoma multiforme (GBM)	A172 cells; U251 cells	temozolomide (TMZ) treatment	"Circ-HIPK3 was obviously increased in TMZ-resistant glioma cells and their exosomes, miR-421, was downregulated in TMZ-resistant glioma"	32644821
79	Human	circHIPK3	circRNA	oleic acid (OA)	hyperglycemia and insulin resistance	HepG2 cells	oleate treatment	upregulated	31875589
80	Human	circHIPK3	circRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	Human-derived cardiomyocytes HCM	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	CircHIPK3 was highly expressed in HCM cells with simulated myocardial I/R relative to those with normoxic treatment	31799682
81	Human	circHIPK3	circRNA	dexamethasone (DEX)	osteoblast injury	OB-6 osteoblastic cells and primary human osteoblasts	dexamethasone (DEX) treatment	circHIPK3 expression was downregulated in DEX-treated human osteoblasts and circHIPK3 levels decreased in human necrotic femoral head tissues. In OB-6 osteoblastic cells and primary human osteoblasts ectopic overexpression of circHIPK3 potently suppressed DEX-induced apoptosis and programmed necrosis.	31242973
82	Human	circHIPK3	circRNA	gemcitabine (GEM)	pancreatic cancer (PC)	Pancreatic cancer tissues; PANC-1 cells; SW-1990 cells	Gemcitabine (GEM) treatment	circHIPK3 was also increased in GEM-resistant PC tumors tissues and GEM-resistant PC cells.	32104074
83	Human	circHIPK3	circRNA	CoCl2	spinal cord injury (SCI)	AGE1.HN	CoCl2 treatment	circ-HIPK3 relieves the neuronal cell apoptosis through regulating miR-588/DPYSL5 axis in SCI.	32247616
84	Human	circHIPK3	circRNA	CoCl2	spinal cord injury (SCI)	AGE1.HN cells	?CoCl2 treatment	Circ_HIPK3 expression was inhibited by CoCl2?in AGE1.HN cells.	33770577
85	Human	circHIPK3	circRNA	high glucose (HG)	vascular injury	human umbilical vein endothelial cells (HUVECs)	high glucose (HG) treatment	downregulated	30454897
86	Human	circHMGCS1	circRNA	sevoflurane (SEV)	colorectal cancer (CRC)	SW480 cells; LOVO cells	sevoflurane treatment	sevoflurane inhibited colon cancer progression by modulating the exosome-transmitted circ-HMGCS1/miR-34a-5p/SGPP1 axis	33125091
87	Human	circINO80	circRNA	Nel-like molecule type 1 (NELL-1)	osteogenesis	human adipose-derived stem cells (hASCs)	"recombinant nel-like molecule, type 1 (NELL-1) treatment"	upregulated	31633307
88	Human	circIQGAP1	circRNA	IL-1¦Â	osteoarthritis (OA)	CHON-001 cells	IL-1¦Â treatment	"Circ-IQGAP1 abundance was enhanced in the cartilage tissues from OA patients compared with normal subjects (n = 32), and its expression was increased in CHON-001 cells after treatment of IL-1¦Â in a dose-dependent pattern."	33675175
89	Human	circITCH	circRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)	doxorubicin treatment	"The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a"	32392088
90	Human	circITCH	circRNA	lidocaine	hepatocellular carcinoma (HCC)	HCC cells	?lidocaine treatment	"circ_ITCH and CPEB3 levels were decreased in hepatocellular carcinoma tissues and cells, and were restored in cells via lidocaine treatment"	33433806
91	Human	circLARP4	circRNA	cisplatin (DDP)	osteosarcoma (OS)	MG63 cells	cisplatin treatment	"Circ-LARP4 high expression correlates with decreased Enneking stage and prolonged survival profiles, and it elevates chemosensitivity to cisplatin and doxorubicin via sponging miR-424 in osteosarcoma."	31642110
92	Human	circLARP4	circRNA	cisplatin and doxorubicin	osteosarcoma (OS)	MG63 cells	cisplatin and doxorubicin treatment	"Circular RNA LARP4 correlates with decreased Enneking stage, better histological response, and prolonged survival profiles, and it elevates chemosensitivity to cisplatin and doxorubicin via sponging microRNA-424 in osteosarcoma."	31642110
93	Human	circLARP4	circRNA	doxorubicin (DOX)	osteosarcoma (OS)	MG63 cells	doxorubicin treatment	"Circ-LARP4 high expression correlates with decreased Enneking stage and prolonged survival profiles, and it elevates chemosensitivity to cisplatin and doxorubicin via sponging miR-424 in osteosarcoma."	31642110
94	Human	circLRP6	circRNA	arsenite	arsenite-induced carcinogenesis	human keratinocyte (HaCaT) cells	arsenite exposure	upregulated	29216394
95	Human	circMCTP2	circRNA	cisplatin (DDP)	gastric cancer (GC)	BGC823	cisplatin (DPP) treatment	CircMCTP2 sensitizes GC to CDDP through the upregulation of MTMR3 by sponging miR-99a-5p.	33198772
96	Human	circMTHFD2	circRNA	pemetrexed	gastric cancer (GC)	Human gastric cancer MGC-803 cells	pemetrexed (MTA) treatment	"Compared with MGC-803/MTA resistant cells, the drug resistance of cells increased significantly in circ MTHFD2 overexpression group"	31841184
97	Human	circMTO1	circRNA	TGF-¦Â1	liver fibrosis	LX©\2 cells	transforming growth factor-¦Â1 (TGF-¦Â1) treatment	downregulated	31148365
98	Human	circNFXL1_009	circRNA	hypoxia	pulmonary arterial hypertension (PAH)	human pulmonary arterial smooth muscle cells (hPASMCs)	hypoxia treatment	exposure to hypoxia markedly reduced the hsa_circNFXL1_009 level in cultured hPASMCs.	33614247
99	Human	circNRIP1	circRNA	hypoxia	gastric cancer (GC)	SGC-7901; AGS; MKN-45; BGC-823	hypoxia treatment	upregulated	32425596
100	Human	circNSUN2	circRNA	aloperine	colorectal cancer (CRC)	SW480 and HT29 cells	aloperine treatment	downregulated	33664565
101	Human	circOSBPL2	circRNA	cigarette smoke extract (CSE)	chronic obstructive pulmonary disease (COPD)	human bronchial epithelial cells (HBECs)	cigarette smoke extract (CSE) treatment	"Circ-OSBPL2 was highly expressed in lung tissues of smokers without or with COPD, particularly in smokers with COPD."	33854310
102	Human	circPAN3	circRNA	doxorubicin (DOX)	acute myeloid leukemia (AML)	human AML cells THP-1 and K562	doxorubicin treatment	"circPAN3 is most likely a key mediator in the development of AML drug resistance, evidenced by the increased expression in ADM-resistant cell lines and BM samples from relapsed patients."	31401408
103	Human	circPHC3	circRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	human brain microvascular endothelial cells (BMECs)	oxygen glucose deprivation (OGD) treatment	CircPHC3 was highly expressed in human BMECs after OGD	33519202
104	Human	circPostn	circRNA	hypoxia/reoxygenation (H/R)	myocardial infarction (MI)	human cardiomyocytes	hypoxia and reoxygenation (H/R) treatment	"We identified that the expression of circPostn was elevated in the plasma of MI patients, MI mouse model, and hypoxia and reoxygenation (H/R)-treated human cardiomyocytes."	33681183
105	Human	circPRKCA	circRNA	curcumin (Cur)	non-small cell lung cancer (NSCLC)	"NSCLC cells (H1650, H1299, H460, A549)"	curcumin treatment	"After curcumin treatment, the expression tendency of circ-PRKCA, miR-384, and ITGB1 in NSCLC cells was overturned."	33684690
106	Human	circPRKCB	circRNA	hypoxia/reoxygenation (H/R)	intestinal ischemia/reperfusion (I/R) injury	Caco-2 cells	hypoxia/reoxygenation (H/R) treatment	circ-PRKCB/miR-339-5p/p66Shc signaling pathway in regulating oxidative stress in the I/R intestine.	32929374
107	Human	circPRKCI	circRNA	lipopolysaccharide (LPS)	HK-2 cells injury	HK-2 cells	Lipopolysaccharide (LPS) treatment	highly expressed circPRKCI relieved inflammatory injury induced by LPS in HK2 cells by suppressing miR-545/ZEBs and depressing the briskness of NF-kB pathway.	32104945
108	Human	circPRKCI	circRNA	H2O2	oxidative stress	SH-SY5Y neuronal cells	H2O2 treatment	downregulated	31053300
109	Human	circPRMT5	circRNA	cisplatin (DDP)	non-small cell lung cancer (NSCLC)	A549 cells; H460 cells	cisplatin treatment	Circ-PRMT5 promoted DDP resistance via REV3L by sponging miR-4458 in NSCLC	32808744
110	Human	circPTPRA	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	Human vascular smooth muscle cell line (VSMCs)	oxidized low-density lipoprotein (ox-LDL) treatment	upregulated	33336764
111	Human	circPUM1	circRNA	insulin	polycystic ovarian syndrome (PCOS)	KGN cells; SVOG cells	insulin treatment	upregulated	32540374
112	Human	circPVT1	circRNA	paclitaxel (PTX)	gastric cancer (GC)	"Human GC tissues and tumor cell lines (MKN-45, HGC-27, MGC-803, and AGS)"	paclitaxel (PTX) treatment	circ-PVT1 expression was upregulated in PTX-resistant GC tissues and cells. Circ-PVT1 downregulated enhanced PTX sensitivity in PTX-resistant GC cells by negatively regulating miR-124-3p.	31793989
113	Human	circPVT1	circRNA	propofol (PPF)	gastric cancer (GC)	HGC-27 cells; AGS cells	Propofol treatment	"Propofol inhibited the proliferation and invasion, but enhanced the apoptosis of GC cells by regulating the circ-PVT1/miR-195-5p/ETS1 axis"	32945521
114	Human	circPVT1	circRNA	cisplatin and pemetrexed	lung adenocarcinoma (LUAD)	A549/DR cells	cisplatin and pemetrexed treatment	circPVT1 contributes to cisplatin and pemetrexed chemotherapy resistance through miR-145-5p/ABCC1 axis.	31986409
115	Human	circPWWP2A	circRNA	mycobacterium tuberculosis (Mtb)	apoptosis	primary human monocyte-derived macrophages	Mycobacterium tuberculosis (MTB) infection	downregulated	31434611
116	Human	circPWWP2A	circRNA	dexamethasone (DEX)	cytotoxicity	DEX-treated human OB-6 osteoblastic cells	dexamethasone (Dex) treatment	cPWWP2A is downregulated in the necrotic femoral head tissues of DEX-taking human patients as well as in DEX-treated human osteoblasts. cPWWP2A silencing or forced miR-579 overexpression induced significant cytotoxicity in human osteoblasts.	31376935
117	Human	circPWWP2A	circRNA	lipopolysaccharide (LPS)	liver fibrosis	human HSC line LX2 cells	lipopolysaccharide (LPS) treatment	upregulated	31719209
118	Human	circPWWP2A	circRNA	TGF-¦Â	liver fibrosis	Human HSC line LX2 cells	TGF-¦Â treatment	upregulated	31719209
119	Human	circRACGAP1	circRNA	apatinib	advanced gastric cancers (AGCs)	BGC-823 and HGC-27	apatinib treatment	Silencing of circRACGAP1 sensitizes gastric cancer cells to apatinib via modulating autophagy by targeting miR-3657 and ATG7	32139670
120	Human	circRELL1	circRNA	oxidized low density lipoprotein (ox-LDL)	endothelial inflammation	human umbilical vein endothelial cells (HUVECs)	oxidized low-density lipoprotein (ox-LDL) treatment	circ-RELL1 modulate inflammatory response by miR-6873-3p/MyD88/NF-¦ÊB axis in ox-LDL induced endothelial cells.	33008595
121	Human	circRFWD2	circRNA	Nel-like molecule type 1 (NELL-1)	osteogenesis	human adipose-derived stem cells (hASCs)	recombinant nel-like molecule type 1 (NELL-1) treatment	upregulated	31633307
122	Human	circRHOT1	circRNA	propofol (PPF)	non-small cell lung cancer (NSCLC)	human bronchial epithelioid(16HBE)	Propofol treatment	"?Importantly, treatment with Propofol inhibited circ-RHOT1 expression in NSCLC cells"	33515563
123	Human	circRIMS2	circRNA	aerobic exercise	vascular cognitive impairment (VCI)	serum	aerobic exercise training (AET) treatment	"Aerobic exercise could shorten the average time that mice reached the platform in the Morris water maze, increase the expression level of circRIMS2 and BDNF, reduce miR-186 expression, and inhibit neuronal apoptosis."	33413076
124	Human	circRSF	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	human aortic endothelial cells (HAECs)	oxidized low-density lipoprotein (ox-LDL) treatment	CircRSF1 could protect against ox-LDL-induced endothelial cell injury in vitro via miR-758/CCND2 axis	32791147
125	Human	circRSF1	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	human umbilical vein endothelial cells (HUVECs)	oxidized low-density lipoprotein (ox-LDL) treatment	"In this study, ox-LDL inhibited circRSF1 and HDAC1 expression while upregulated miR-135b-5p expression in Human umbilical vein endothelial cells (HUVECs)."	33757583
126	Human	circRSF1	circRNA	radiation	radiation-induced liver disease (RILD)	LX2 cells	radiation treatment	CircRNA RSF1 (circRSF1) was upregulated in irradiated LX2 cells	31960423
127	Human	circS-7	circRNA	IL-1¦Â	osteoarthritis (OA)	Human OA chondrocytes (C28/12 cell line)	IL-1¦Â treatment	downregulated	30925324
128	Human	circS-7	circRNA	ultraviolet (UV) irradiation	pigmented skin diseases	HaCaT cells; FB cells	Ultraviolet B (UVB)? treatment	upregulated	33687273
129	Human	circSEC24A	circRNA	IL-1¦Â	osteoarthritis (OA)	human chondrocytes	IL-1¦Â treatment	"CircSEC24A and SOX5 expression were enhanced, while miR-142-5p level was reduced in OA cartilage tissues and chondrocytes."	33751650
130	Human	circSEMA4B	circRNA	IL-1¦Â	intervertebral disc degeneration (IDD)	NPC	IL-1¦Â treatment	IL-1¦Â stimulation also dramatically inhibited circSEMA4B expression.	30251693
131	Human	circSERPINE2	circRNA	IL-1¦Â	osteoarthritis (OA)	CHON-001 cells	IL-1¦Â treatment	CircSERPINE2 could mediate TGFBR2 expression by binding with miR-495.	33094798
132	Human	circSFMBT2	circRNA	platelet derived growth factor-BB (PDGF-BB)	proliferative vascular diseases	Human VSMCs	platelet derived growth factor-BB (PDGF-BB) treatment	circSFMBT2 plays a vital role in VSMC proliferation and migration through the miR-331/HDAC5/Aggf1 axis	33166591
133	Human	circSFMBT2	circRNA	platelet derived growth factor-BB (PDGF-BB)	proliferative vascular diseases	vascular smooth muscle cell (VSMC)	platelet derived growth factor-BB (PDGF-BB) treatment	upregulated	33166591
134	Human	circSLC7A6	circRNA	matrine	colorectal cancer (CRC)	cancer-associated fibroblasts	matrine treatment	circRNAs (circSLC7A6) was significantly downregulated in CM of CAFs with matrine treatment.	32423804
135	Human	circSMARCA5	circRNA	cisplatin and gemcitabine	non-small cell lung cancer (NSCLC)	NCI©\H1299 cells; NCI©\H1437 cells	cisplatin and gemcitabine treatment	Circular RNA SMARCA5 may serve as a tumor suppressor in non-small cell lung cancer.	31944395
136	Human	circSMARCA5	circRNA	double hydrogen testosterone (DHT)	prostate cancer	LNCaP cells	double hydrogen testosterone (DHT) treatment	upregulated	28765045
137	Human	circSORE	circRNA	sorafenib (SOR)	hepatocellular carcinoma (HCC)	HepG2 cells; SKhep1 cells; Huh7 cells; LM3 cells	sorafenib treatment	upregulated	33222692
138	Human	circTADA2A	circRNA	platelet derived growth factor-BB (PDGF-BB) and insulin-like growth factor (IGF)-1	idiopathic pulmonary fibrosis (IPF)	human fibroblastic cell line (LL-24)	PDGF-BB and IGF-1 treatment	circTADA2A repressed lung-fibroblasts activation via miR-526b/Cav1 and reduced lung-fibroblasts proliferation via miR-203/Cav2	32694556
139	Human	circTIMP2	circRNA	TNF-¦Á and IL-1¦Â	intervertebral disc degeneration (IDD)	NP cells	TNF-¦Á and IL-1¦Â treatment	circ-TIMP2 promoted TNF-¦Á- and IL-1¦Â-induced NP cell imbalance between ECM anabolism and catabolism via miR-185-5p-MMP2 signaling	32626912
140	Human	circTM7SF3	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	THP-1-derived macrophages and differentiated human monocyte-derived macrophages (hMDMs)	oxidized low-density lipoprotein (ox-LDL) treatment	CircTM7SF3 level was markedly increased in the serum samples of AS patients and ox-LDL-induced THP-1-derived macrophages compared with their matching counterparts.	33526034
141	Human	circTMBIM6	circRNA	IL-1¦Â and TNF-¦Á	osteoarthritis (OA)	Chondrocytes	IL-1¦Â and TNF-¦Á treatment	CircTMBIM6 promotes osteoarthritis-induced chondrocyte extracellular matrix degradation via miR-27a/MMP13 axis.	32767318
142	Human	circTtc3	circRNA	hypoxia	pressure ulcer (PU)	HaCaT cells	hypoxia treatment	circ-Ttc3 alleviated hypoxic injury and activated NF-¦ÊB and PI3K/AKT pathways by downregulating miR-449a in HaCaT cells.	32043754
143	Human	circTUBD1	circRNA	irradiation and lipopolysaccharide (LPS)	radiation-induced liver disease (RILD)	LX-2 cells	irradiation and lipopolysaccharide (LPS) treatment	Circular RNA TUBD1 Acts as the miR-146a-5p Sponge to Affect the Viability and Pro-Inflammatory Cytokine Production of LX-2 Cells through the TLR4 Pathway.	32097101
144	Human	circUBE2G1	circRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	C28/I2 cells	lipopolysaccharide (LPS) treatment	circRNA-UBE2G1 facilitates the progression in the LPS-induced OA cell model via regulating the miR-373/HIF-1a axis.	32476580
145	Human	circUSP36	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	human umbilical vein smooth muscle cells (HUVSMCs)	oxidized low-density lipoprotein (ox-LDL) treatment	Knockdown of circ_USP36 alleviated ox-LDL-mediated injury of HUVSMCs by modulating miR-182-5p/KLF5 axis	33437365
146	Human	circUSP36	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	human umbilical vein endothelial cells (HUVECs)	oxidized low-density lipoprotein (ox-LDL) treatment	Ox-LDL exposure induced the upregulation of circ-USP36 in HUVEC cells.	33249762
147	Human	circUSP36	circRNA	oxidized low density lipoprotein (ox-LDL)	endothelial cell injury	human umbilical vein endothelial cells (HUVECs)	oxidized low-density lipoprotein (ox-LDL) treatment	Ox-LDL exposure induced the upregulation of circ-USP36 in HUVEC cells.	33249762
148	Human	circUSP45	circRNA	glucocorticoid (GC)	glucocorticoid-induced osteonecrosis of femoral head (GIONFH)	femoral heads	glucocorticoids (GCs) treatment	upregulated	30579595
149	Human	circUSP45	circRNA	glucocorticoid (GC)	glucocorticoid-induced osteonecrosis of femoral head (GIONFH)	human Bone mesenchymal stem cells (BMSCs)	glucocorticoids (GCs) treatment	upregulated	30579595
150	Human	circVEGFC	circRNA	high glucose (HG)	diabetes mellitus (DM)	human umbilical vein endothelial cells (HUVECs)	high glucose (HG) treatment	upregulated	32680978
151	Human	circVIRF4	circRNA	Kaposi¡¯s sarcoma-associated herpesvirus (KSHV)	kaposi¡¯s sarcoma-associated herpesvirus (KSHV) infection	primary effusion lymphoma (PEL) cell lines	Kaposi¡¯s sarcoma-associated herpesvirus (KSHV) infection	upregulated	31911496
152	Human	circVMA21	circRNA	lipopolysaccharide (LPS)	sepsis	THP-1 cells	lipopolysaccharide (LPS) treatment	"CircVMA21 and NRP1 were decreased, and miR-199a-5p was increased in LPS-induced THP-1 cells."	33647793
153	Human	circVPS13C	circRNA	propofol (PPF)	ovarian cancer (OC)	ovarian cancer cell lines (A2780 and SKOV3)	Propofol treatment	Propofol suppressed the progression of ovarian cancer through up-regulating miR-145 via suppressing circVPS13C	33563314
154	Human	circVPS18	circRNA	temozolomide (TMZ)	glioblastoma multiforme (GBM)	U251 cells; LN229 cells; glioma tissues	temozolomide (TMZ) treatment	Circ-VPS18 expression was upregulated in TMZ-resistant glioma tissues and glioma cells	33188501
155	Human	circWBSCR17	circRNA	high glucose (HG)	diabetic nephropathy (DN)	HK-2 cells	high glucose (HG) treatment	Circ_WBSCR17 aggravates inflammatory responses and fibrosis by targeting miR-185-5p/SOX6 regulatory axis in high glucose-induced human kidney tubular cells	32798559
156	Human	circWDR77	circRNA	high glucose (HG)	diabetes mellitus (DM)	human vascular smooth muscle cells (VSMCs)		upregulated	29042195
157	Human	circZC3H4	circRNA	SiO2	epithelial-mesenchymal transition (EMT)	MLE-12 cells	SiO2 treatment	upregulated	30826420
158	Human	circZC3H4	circRNA	silicon dioxide (SiO2)	lung fibrosis	lung tissues	silicon dioxide (SiO2) treatment	upregulated	29401612
159	Human	circZNF292	circRNA	hypoxia	hepatocellular carcinoma (HCC)	hepatoma SMMC7721 cells	hypoxia induce	upregulated	31028816
160	Human	circZNF609	circRNA	bovine serum albumin (BSA)	focal segmental glomerulosclerosis (FSGS)	HK-2 cells	bovine serum albumin (BSA) treatment	upregulated	32800553
161	Human	circZNF609	circRNA	H2O2	oxidative stress	HaCaT cells	H2O2 treatment	Anti-antioxidant impacts of circZNF609 silence in HaCaT cells through regulating miR-145	33821719
162	Human	circZNF652	circRNA	lipopolysaccharide (LPS)	infantile pneumonia (IP)	WI-38 cells	lipopolysaccharide (LPS) treatment	LPS inducement remarkably enhanced the expression of circZNF652.	31889339
163	Human	circZNF652	circRNA	lipopolysaccharide (LPS)	infantile pneumonia (IP)	WI-38 cells	lipopolysaccharide (LPS) treatment	upregulated	31889339
164	Human	hsa_circ_0000109	circRNA	high glucose (HG)	diabetes-associated endothelial dysfunction	human umbilical vein endothelial cells (HUVECs)	?high glucose (HG) induce treatment	dysregulated	31369204
165	Human	hsa_circ_0000199	circRNA	cisplatin (DDP)	gastric cancer (GC)	"GC tissues and cells SGC7901, BGC823"	cisplatin treatment	upregulated	30927924
166	Human	hsa_circ_0000260	circRNA	cisplatin (DDP)	gastric adenocarcinoma (GAC)	HGC27; AGS	cisplatin treatment	Circ_0000260 Regulates the Development and Deterioration of Gastric Adenocarcinoma with Cisplatin Resistance by Upregulating MMP11 via Targeting MiR-129-5p.	33122949
167	Human	hsa_circ_0000285	circRNA	cisplatin (DDP)	bladder cancer	bladder cancer tissues	cisplatin treatment	hsa_circ_0000285 expression was lower in cisplatin-resistant bladder cancer patients than in those who were cisplatin-sensitive.	30509102
168	Human	hsa_circ_0000285	circRNA	cisplatin (DDP)	bladder cancer	serum	cisplatin treatment	hsa_circ_0000285 expression was lower in cisplatin-resistant bladder cancer patients than in those who were cisplatin-sensitive.	30509102
169	Human	hsa_circ_0000376	circRNA	hypoxia	non-small cell lung cancer (NSCLC)	H522; H1975; BEAS-2B	hypoxia treatment	Circ_0000376 promoted NSCLC progression by regulating the miR-1182/NOVA2 axis	32922073
170	Human	hsa_circ_000042	circRNA	curcumin (Cur)	nasopharyngeal carcinoma (NPC)	CNE-2R cells	curcumin treatment	downregulated	31793078
171	Human	hsa_circ_0000504	circRNA	5-fluorouracil (5-Fu)	colorectal cancer (CRC)	"human CRC cell line, HCT116"	5-fluorouracil (5-FU) treatment	upregulated	28656150
172	Human	hsa_circ_0000524	circRNA	angiotensin II (Ang II)	membranous nephropathy (MN)	podocytes	angiotensin II (Ang II) treatment	"AngII treatment induced the overexpression of circ_0000524 and CXCL16, a decrease of miR-500a-5p, and induced cell apoptosis in podocytes."	32974919
173	Human	hsa_circ_0000524	circRNA	angiotensin II (Ang II)	membranous nephropathy (MN)	AB8/13 podocytes	angiotensin II (Ang II) treatment	"AngII treatment induced the overexpression of circ_0000524 and CXCL16, a decrease of miR-500a-5p."	32974919
174	Human	hsa_circ_0000567	circRNA	gefitinib	non-small cell lung cancer (NSCLC)	HCC827 cells; PC9 cells	gefitinib treatment	upregulated	32328186
175	Human	hsa_circ_0000592	circRNA	N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)	gastric cancer (GC)	malignant-transformed gastric epithelial cells (GES-1-T); normal gastric epithelial cells (GES-1-N)	N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) treatment	upregulated	31189743
176	Human	hsa_circ_0000638	circRNA	neodymium oxide (Nd2O3)	inflammation	human bronchial epithelial (16HBE) cells	neodymium oxide treatment	circRNA_0000638 was downregulated in neodymium oxide-treated 16HBE cells.	32199215
177	Human	hsa_circ_0000657	circRNA	microcystin-leucine arginine (MC-LR)	hepatotoxicity	human normal liver cell line (HL7702)	MC-LR exposure	downregulated	31825292
178	Human	hsa_circ_0000659	circRNA	microcystin-leucine arginine (MC-LR)	hepatotoxicity	human normal liver cell line (HL7702)	MC-LR exposure	downregulated	31825292
179	Human	hsa_circ_0000735	circRNA	docetaxel (DTX)	prostate cancer	PC-3 cells; DU145 cells	docetaxel (DTX) treatment	Hsa_circ_0000735 was upregulated in DTX-resistant PCa tissues and cells.	32714093
180	Human	hsa_circ_0000977	circRNA	hypoxia	pancreatic cancer (PC)	NK cells	hypoxia induce	upregulated	31402756
181	Human	hsa_circ_0001013	circRNA	5-fluorouracil (5-Fu)	osteosarcoma (OS)	MG63 cells	5-fluorouracil (5-FU) treatment	upregulated	33308021
182	Human	hsa_circ_0001085	circRNA	IFN-¦Ã	epithelial-mesenchymal transition (EMT)	PC-3M IE8 cells	interferon-¦Ã (IFN-¦Ã) treatment	downregulated in PC-3M IE8 cells in the EMT induction model	31882179
183	Human	hsa_circ_0001085	circRNA	IFN-¦Ã	epithelial-mesenchymal transition (EMT)	PC-3M IE8 cells	IFN-¦Ã treatment	downregulated	31882179
184	Human	hsa_circ_0001165	circRNA	IFN-¦Ã	epithelial-mesenchymal transition (EMT)	PC-3M IE8 cells	interferon-¦Ã (IFN-¦Ã) treatment	upregulated in PC-3M IE8 cells in the EMT induction model	31882179
185	Human	hsa_circ_0001165	circRNA	IFN-¦Ã	epithelial-mesenchymal transition (EMT)	PC-3M IE8 cells	IFN-¦Ã treatment	Hsa_circ_0001165 was upregulated in PC-3M IE8 cells treatment with IFN-¦Ã.	31882179
186	Human	hsa_circ_0001173	circRNA	high glucose (HG)	gestational diabetes mellitus (GDM)	HTR-8 cellsS;Vneo cells	high-glucose (HG) treatment	"In GDM patients, the expression of circ_0008285 was significantly upregulated, while that of circ_0001173 was decreased."	33879262
187	Human	hsa_circ_0001204	circRNA	mycobacterium tuberculosis (Mtb)	tuberculosis (TB)	human monocyte derived macrophages (MDMs)	infect with Mtb	dysregulated	29057952
188	Human	hsa_circ_0001313	circRNA	radiation	colorectal cancer (CRC)	colon cancer tissues	radiation treatment	circ_0001313 was significantly upregulated and miR-338-3p was downregulated in radio-resistant colon cancer tissues compared to radio-sensitive tissues	30630646
189	Human	hsa_circ_0001313	circRNA	X-rays	colorectal cancer (CRC)	SW480 and SW620 cells	6-MV X-ray exposure	Radiation treatment in colon cells triggered a remarkable upregulation of circ_0001313 and a downregulated of miR-338-3p.	30630646
190	Human	hsa_circ_000139	circRNA	XAV939	non-small cell lung cancer (NSCLC)	NCL-H1299?cells	XAV939 treatment	"Circ_MDM2_000139, Circ_ATF2_001418, Circ_CDC25C_002079, and Circ_BIRC6_001271 Are Involved in the Functions of XAV939 in Non-Small Cell Lung Cancer"	31885751
191	Human	hsa_circ_0001445	circRNA	oxidized low density lipoprotein (ox-LDL)	inflammatory injury	human umbilical vein endothelial cells (HUVECs)	oxidized low-density lipoprotein (ox-LDL) treatment	Hsa_ circ_0001445 expression was gradually decreased with the increase of OX-LDL concentration.	33300444
192	Human	hsa_circ_0001535	circRNA	microcystin-leucine arginine (MC-LR)	hepatotoxicity	human normal liver cell line (HL7702)	MC-LR exposure	upregulated	31825292
193	Human	hsa_circ_0001946	circRNA	cisplatin (DDP)	non-small cell lung cancer (NSCLC)	"human normal lung fibroblasts cell line MRC-5, human NSCLC cell line A549, cisplatin-resistant cell line A549/DDP"	cisplatin treatment	hsa_circ_0001946 can affect the sensitivity of NSCLC cells to the chemotherapeutic drug cisplatin via modulation of the NER signaling pathway.	31249811
194	Human	hsa_circ_0001953	circRNA	mycobacterium tuberculosis (Mtb)	tuberculosis (TB)	plasma	Mycobacterium tuberculosis (Mtb) infection	upregulated	30214434
195	Human	hsa_circ_0002142	circRNA	hypoxia	glioblastoma multiforme (GBM)	"The normal human astrocyte line SVGp12 and two human glioma cell lines, U87MG and A172"	hypoxia induce	upregulated	30988674
196	Human	hsa_circ_0002317	circRNA	high glucose (HG)	diabetes-associated endothelial dysfunction	human umbilical vein endothelial cells (HUVECs)	?high glucose (HG) induce treatment	dysregulated	31369204
197	Human	hsa_circ_0002468	circRNA	retinoic acid (RA)	human neuronal differentiation	SH-SY5Y cells	retinoic acid (RA) treatment	The expression of hsa_circ_0002468 was increased during SH-SY5Y differentiation and was inversely correlated with miR-561 expression.	30951518
198	Human	hsa_circ_0002570	circRNA	high glucose (HG)	diabetic retinopathy (DR)	human retinal microvascular endothelial cells (hRMECs)	high glucose treatment	circ_0002570 could upregulate angiomotin by targeting miR-1243 to mediate the dysfunction of hRMECs induced by high glucose.	32319024
199	Human	hsa_circ_0002594	circRNA	corticosteroid	allergic asthma (AA)	CD4+ T cells	inhaled corticosteroids (ICS) treatment	Hsa_circ_0002594 was decreased after inhaled corticosteroids (ICS) treatment.	33326955
200	Human	hsa_circ_0002755	circRNA	sevoflurane (SEV)	glioblastoma multiforme (GBM)	A-172; SHG-44	Sevoflurane (Sev) treatment	Sev mediated glioma progression via circ_0002755/miR-628-5p/MAGT1 axis	32669871
201	Human	hsa_circ_0003204	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	human aorta endothelial cells (HAECs)	oxidized low-density lipoprotein (ox-LDL) treatment	upregulated	31900142
202	Human	hsa_circ_0003247	circRNA	microcystin-leucine arginine (MC-LR)	hepatotoxicity	human normal liver cell line (HL7702)	MC-LR exposure	upregulated	31825292
203	Human	hsa_circ_0003250	circRNA	high glucose (HG)	diabetes-associated endothelial dysfunction	human umbilical vein endothelial cells (HUVECs)	?high glucose (HG) induce treatment	dysregulated	31369204
204	Human	hsa_circ_0003418	circRNA	cisplatin (DDP)	hepatocellular carcinoma (HCC)	"Human HCC cell lines (Hep-3B, Huh-7, Sk-hep-1, SMMC7721 and PLC)"	cisplatin treatment	suppression of circ_0003418 enhanced cisplatin resistance of HCC cells in vivo and vitro.	31807029
205	Human	hsa_circ_0003420	circRNA	lipopolysaccharide (LPS)	sepsis-induced liver injury	Kupffer cells	lipopolysaccharide (LPS) treatment	We observed circ_0003420 upregulation accompanied by NPAS4 downregulated in liver samples from patients with sepsis-associated damage and in Kupffer cells treated with LPS.	33719821
206	Human	hsa_circ_0003489	circRNA	hypoxia	osteogenesis	periodontitis tissues	hypoxia treatment	"The expression levels of circCDK8 and hypoxia-inducible factor-1¦Á were significantly increased in periodontitis tissues, and the expression of circCDK8 was further confirmed in a hypoxia model using cobalt chloride (CoCl2?)."	32978798
207	Human	hsa_circ_0003524	circRNA	mycobacterium tuberculosis (Mtb)	tuberculosis (TB)	plasma	Mycobacterium tuberculosis (Mtb) infection	upregulated	30214434
208	Human	hsa_circ_0003528	circRNA	mycobacterium tuberculosis (Mtb)	tuberculosis (TB)	plasma	Mycobacterium tuberculosis (Mtb) infection	upregulated	30214434
209	Human	hsa_circ_0003546	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	human THP-1 macrophages	oxidized low-density lipoprotein (ox-LDL) treatment	dysregulated	31804889
210	Human	hsa_circ_0003575	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	HUVECs	oxidized low-density lipoprotein (ox-LDL) treatment	upregulated	28946214
211	Human	hsa_circ_0003645	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	human umbilical vein endothelial cells (HUVECs)	oxidized low-density lipoprotein (ox-LDL) treatment	upregulated	32554046
212	Human	hsa_circ_0003865	circRNA	melatonin	osteoporosis	human bone marrow mesenchymal stem cell (hBMSC)	melatonin (MEL) treatment	Circ_0003865 expression in BMSCs was significantly decreased by MEL treatment.	33632317
213	Human	hsa_circ_0003928	circRNA	high glucose (HG)	diabetic nephropathy (DN)	HK-2 cells	high glucose (HG) treatment	Hsa_circ_0003928 was increased in HG-induced HK-2 cells.	32982348
214	Human	hsa_circ_0004018	circRNA	salvianolic acid B (Sal B)	liver fibrosis	hepatic stellate cells (HSCs)	salvianolic acid B treatment	Hsa_circ_0004018 were significantly upregulated over time as the HSCs were treated with 100 ug/L of Sal B	32584784
215	Human	hsa_circ_0004018	circRNA	salvianolic acid B (Sal B)	liver fibrosis	primary hepatic stellate cells (HSCs)	salvianolic acid B treatment	hsa_circ_0004018 were significantly upregulated over time as the HSCs were treated with 100 ug/L of Sal B	32584784
216	Human	hsa_circ_0004058	circRNA	H2O2	age-related cataract (ARC)	human lens epithelial B3 (HLE-B3) cells	H2O2 treatment	Our data showed that circZNF292 was downregulated in ARC tissues and H2O2-treated human lens epithelial B3 (HLE-B3) cells.	33851769
217	Human	hsa_circ_0004812	circRNA	hepatitis B virus (HBV)	chronic hepatitis B virus (HBV) infection	Huh7 cells; HepG2 cells	pHBV1.3 infection	The level of circ_0004812 was significantly increased in the pHBV1.3-infected cells.	32188476
218	Human	hsa_circ_0004872	circRNA	platelet derived growth factor-BB (PDGF-BB)	atherosclerosis (AS)	human aortic vascular smooth muscle cells (HA-VSMCs)	platelet derived growth factor-BB (PDGF-BB)?treatment treatment	Circ_0004872 expression was elevated in PDGF-BB-induced human aortic vascular smooth muscle cells (HA-VSMCs) and carotid plaque tissues	33592319
219	Human	hsa_circ_0004916	circRNA	IFN-¦Ã	epithelial-mesenchymal transition (EMT)	PC-3M IE8 cells	interferon-¦Ã (IFN-¦Ã) treatment	downregulated in PC-3M IE8 cells in the EMT induction model	31882179
220	Human	hsa_circ_0004916	circRNA	IFN-¦Ã	epithelial-mesenchymal transition (EMT)	PC-3M IE8 cells	IFN-¦Ã treatment	downregulated	31882179
221	Human	hsa_circ_0005105	circRNA	IL-1¦Â	osteoarthritis (OA)	human Chondrocytes-articular	IL-1¦Â treatment	upregulated	28276108
222	Human	hsa_circ_0005263	circRNA	high glucose (HG)	diabetes-associated endothelial dysfunction	human umbilical vein endothelial cells (HUVECs)	?high glucose (HG) induce treatment	dysregulated	31369204
223	Human	hsa_circ_0005694	circRNA	5-fluorouracil (5-Fu)	osteosarcoma (OS)	MG63 cells	5-fluorouracil (5-FU) treatment	downregulated	33308021
224	Human	hsa_circ_0005741	circRNA	high glucose (HG)	diabetes-associated endothelial dysfunction	human umbilical vein endothelial cells (HUVECs)	?high glucose (HG) induce treatment	dysregulated	31369204
225	Human	hsa_circ_0005941	circRNA	cisplatin (DDP)	non-small cell lung cancer (NSCLC)	A549 cells	cisplatin treatment	downregulated	32767026
226	Human	hsa_circ_0005963	circRNA	oxaliplatin	colorectal cancer (CRC)	SW480 cells; HCT116 cells	oxaliplatin treatment	upregulated	31901148
227	Human	hsa_circ_0006294	circRNA	sorafenib (SOR)	hepatocellular carcinoma (HCC)	Huh-7 cells; HepG2 cells	sorafenib treatment	downregulated	32226514
228	Human	hsa_circ_0006393	circRNA	dexamethasone (DEX)	glucocorticoid-induced osteoporosis (GIOP)	Bone tissue	dexamethasone (DEX) treatment	"the expression level of hsa_circ_0006393 was decreased in patients with GIOP. Furthermore, the overexpression of hsa_circ_0006393 increased the expression level of genes associated with osteogenesis."	31322188
229	Human	hsa_circ_0006766	circRNA	ultraviolet (UV) irradiation	photoaging	human dermal fibroblasts (HDFs)	ultraviolet A (UVA)-irradiated treatment	downregulated	33093901
230	Human	hsa_circ_0006867	circRNA	gefitinib	non-small cell lung cancer (NSCLC)	HCC827 cells; PC9 cells	gefitinib treatment	downregulated	32328186
231	Human	hsa_circ_0006872	circRNA	cigarette smoke extract (CSE)	chronic obstructive pulmonary disease (COPD)	Human pulmonary microvascular endothelial cells HPMECs and bronchial epithelial cells BEAS-2B	cigarette smoke extract (CSE) treatment	upregulated	33248690
232	Human	hsa_circ_0006872	circRNA	cigarette smoke extract (CSE)	chronic obstructive pulmonary disease (COPD)	HPMECs and BEAS-2B cells	cigarette smoke extract (CSE) exposure	"Hsa_circ_0006872 facilitated CSE-triggered apoptosis, inflammation and oxidative stress in HPMECs and BEAS-2B cells by regulating miR-145-5p/NF-¦ÊB pathway."	33248690
233	Human	hsa_circ_0006892	circRNA	cigarette smoke extract (CSE)	chronic obstructive pulmonary disease (COPD)	The bronchial epithelial cells (BEAS-2B and 16HBE)	cigarette smoke extract (CSE) treatment	Circ_0006892 expression was reduced in lung tissues of smokers with COPD and CSE-stimulated bronchial epithelial cells.	33734482
234	Human	hsa_circ_0007006	circRNA	5-fluorouracil (5-Fu)	colorectal cancer (CRC)	"human CRC cell line, HCT116"	5-fluorouracil (5-FU) treatment	upregulated	28656150
235	Human	hsa_circ_0007031	circRNA	5-fluorouracil (5-Fu)	colorectal cancer (CRC)	"human CRC cell line, HCT116"	5-fluorouracil (5-FU) treatment	upregulated	28656150
236	Human	hsa_circ_0007031	circRNA	5-fluorouracil (5-Fu)	colorectal cancer (CRC)	HCT116 cells; Caco2 cells	5-fluorouracil (5-FU) treatment	Circ_0007031 expression was markedly increased in CRC resistant cells.	32982440
237	Human	hsa_circ_0007386	circRNA	5-fluorouracil (5-Fu)	osteosarcoma (OS)	MG63 cells	5-fluorouracil (5-FU) treatment	downregulated	33308021
238	Human	hsa_circ_0007623	circRNA	hypoxia	myocardial ischaemic injury	human umbilical vein endothelial cells (HUVECs)	hypoxia treatment	"hsa_circ_0007623 can bind to miR-297, promote cardiac repair after acute myocardial ischemia, and protect cardiac function."	31973814
239	Human	hsa_circ_0007976	circRNA	high glucose (HG)	diabetes-associated endothelial dysfunction	human umbilical vein endothelial cells (HUVECs)	?high glucose (HG) induce treatment	dysregulated	31369204
240	Human	hsa_circ_0008285	circRNA	high glucose (HG)	gestational diabetes mellitus (GDM)	HTR-8 cellsS;Vneo cells	high-glucose (HG) treatment	"In GDM patients, the expression of circ_0008285 was significantly upregulated, while that of circ_0001173 was decreased."	33879262
241	Human	hsa_circ_0008297	circRNA	mycobacterium tuberculosis (Mtb)	tuberculosis (TB)	plasma	Mycobacterium tuberculosis (Mtb) infection	upregulated	30214434
242	Human	hsa_circ_0008305	circRNA	TGF-¦Â1	non-small cell lung cancer (NSCLC)	A549 cells; H226 cells	TGF-¦Â1 treatment	circ_0008305 was significantly downregulated in NSCLC cells undergoing EMT induced by TGF-¦Â	30261900
243	Human	hsa_circ_0008360	circRNA	high glucose (HG)	diabetes-associated endothelial dysfunction	human umbilical vein endothelial cells (HUVECs)	?high glucose (HG) induce treatment	dysregulated	31369204
244	Human	hsa_circ_0008362	circRNA	5-fluorouracil (5-Fu)	osteosarcoma (OS)	MG63 cells	5-fluorouracil (5-FU) treatment	downregulated	33308021
245	Human	hsa_circ_0008450	circRNA	hypoxia	hepatocellular carcinoma (HCC)	SNU-387 cells; Huh7 cells	hypoxia treatment	Circ_0008450 was upregulated in hypoxia-disposed HCC cells.	33193848
246	Human	hsa_circ_0009024	circRNA	mycobacterium tuberculosis (Mtb)	tuberculosis (TB)	plasma	Mycobacterium tuberculosis (Mtb) infection	upregulated	30214434
247	Human	hsa_circ_000926	circRNA	gemcitabine (GEM)	pancreatic cancer (PC)	SWl990 cells	gemcitabine (GEM) treatment	downregulated	29781033
248	Human	hsa_circ_0009910	circRNA	imatinib	chronic myeloid leukemia (CML)	K562 cells; serum	imatinib treatment	The expression of circ_0009910 was upregulated in the serum of imatinib-resistance CML patients and K562/R cells.	31923418
249	Human	hsa_circ_0010283	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	human vascular smooth muscle cells (VSMCs)	oxidized low-density lipoprotein (ox-LDL) treatment	circ_0010283 mediated cell viability and migration via a miR-370-3p/HMGB1 axis in ox-LDL-induced VSMCs.	32945389
250	Human	hsa_circ_0010283	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	human VSMCs (HVSMCs)	oxidized low-density lipoprotein (ox-LDL) treatment	circ_0010283 participated in ox-LDL-induced dysfunctions of HVSMCs by modulating the miR-133a-3p/PAPPA pathway.	33162460
251	Human	hsa_circ_0010729	circRNA	hypoxia	ischemic heart disease (IHD)	AC16 cell	hypoxia exposure	circ_0010729 knockdown alleviated hypoxia-induced AC16 cell injuries by mediating the miR-27a-3p/TRAF5 axis.	33010282
252	Human	hsa_circ_0010729	circRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic heart disease (IHD)	human cardiomyocytes (HCM)	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	"OGD treatment enhanced circ_0010729 expression and evoked cell injury in HCM Moreover, OGD-induced injury was aggrandized by circ_0010729 overexpression via suppressing cell growth and migration in HCM"	31482388
253	Human	hsa_circ_0010729	circRNA	hypoxia	"vascular endothelial cell proliferation , apoptosis"	human umbilical vein endothelial cells (HUVECs)	hypoxia treatment	upregulated	28571741
254	Human	hsa_circ_0011129	circRNA	ultraviolet (UV) irradiation	photoaging	human dermal fibroblasts (HDFs)	ultraviolet A (UVA)-irradiated treatment	downregulated	33093901
255	Human	hsa_circ_00116639	circRNA	5-fluorouracil (5-Fu)	osteosarcoma (OS)	MG63 cells	5-fluorouracil (5-FU) treatment	upregulated	33308021
256	Human	hsa_circ_001175	circRNA	high glucose (HG)	high glucose (HG) disease	human umbilical vein endothelial cells (HUVECs)	high glucose (HG) treatment	Glucose treatments gradually decreased the expressions of circRNA-001175 in a concentration dependent manner.	30521417
257	Human	hsa_circ_0012129	circRNA	sevoflurane (SEV)	glioblastoma multiforme (GBM)	T98G cell; LN229 cells	sevoflurane (Sev) treatment	Circ_0012129 was downregulated in sevoflurane-treated glioma cells	32495888
258	Human	hsa_circ_001271	circRNA	XAV939	non-small cell lung cancer (NSCLC)	NCL-H1299?cells	XAV939 treatment	"Circ_MDM2_000139, Circ_ATF2_001418, Circ_CDC25C_002079, and Circ_BIRC6_001271 Are Involved in the Functions of XAV939 in Non-Small Cell Lung Cancer"	31885751
259	Human	hsa_circ_001418	circRNA	XAV939	non-small cell lung cancer (NSCLC)	NCL-H1299?cells	XAV939 treatment	"Circ_MDM2_000139, Circ_ATF2_001418, Circ_CDC25C_002079, and Circ_BIRC6_001271 Are Involved in the Functions of XAV939 in Non-Small Cell Lung Cancer"	31885751
260	Human	hsa_circ_0015879	circRNA	mycobacterium tuberculosis (Mtb)	tuberculosis (TB)	plasma	Mycobacterium tuberculosis (Mtb) infection	upregulated	30214434
261	Human	hsa_circ_0020394	circRNA	puerarin	bladder cancer	T24 cells; UM-UC-3 cells	puerarin treatment	circ_0020394 was downregulated in puerarin-treated bladder cancer cells	33016781
262	Human	hsa_circ_002079	circRNA	XAV939	non-small cell lung cancer (NSCLC)	NCL-H1299?cells	XAV939 treatment	"Circ_MDM2_000139, Circ_ATF2_001418, Circ_CDC25C_002079, and Circ_BIRC6_001271 Are Involved in the Functions of XAV939 in Non-Small Cell Lung Cancer"	31885751
263	Human	hsa_circ_0026344	circRNA	CCL20 and CXCL8	colorectal cancer (CRC)	human CRC cell lines SW480 and Caco-2	?CCL20 and CXCL8 co-stimulation	"Highlights CCL20 and CXCL8 synergize to decrease the expression of circ_0026344; Silence of circ_0026344 promotes CRC cells migration, invasion and EMT process"	31608699
264	Human	hsa_circ_0027492	circRNA	doxorubicin (DOX)	DNA damage	HCT116 cells; RKO cells; SW48 cells	Doxorubicin (DOXO) treatment	Hsa_circ_0027492 is upregulated in a p53-dependent manner in response to DNA damage.	32041821
265	Human	hsa_circ_0028198	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	human THP-1 macrophages	oxidized low-density lipoprotein (ox-LDL) treatment	dysregulated	31804889
266	Human	hsa_circ_0029589	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	human vascular smooth muscle cells (VSMCs)	oxidized low-density lipoprotein (ox-LDL) treatment	Circ_0029589 silence might inhibit the progression of AS by regulating miR-424-5p/IGF2 axis	32860985
267	Human	hsa_circ_0030411	circRNA	cisplatin (DDP)	non-small cell lung cancer (NSCLC)	A549 cells	cisplatin treatment	upregulated	32767026
268	Human	hsa_circ_0031250	circRNA	genistein	non-small cell lung cancer (NSCLC)	human NSCLC cell lines (H292 and A549)	genistein treatment	"circ_0031250 abundance was elevated in NSCLC samples and cell lines, and it was reduced via genistein exposure."	33159503
269	Human	hsa_circ_0031250	circRNA	genistein	non-small cell lung cancer (NSCLC)	H292 cells; A549 cells	Genistein treatment	"circ_0031250 abundance was elevated in NSCLC samples and cell lines, and it was reduced via genistein exposure."	33159503
270	Human	hsa_circ_003211	circRNA	curcumin (Cur)	nasopharyngeal carcinoma (NPC)	CNE-2R cells	curcumin treatment	downregulated	31793078
271	Human	hsa_circ_003251	circRNA	gemcitabine (GEM)	pancreatic cancer (PC)	SWl990 cells	gemcitabine (GEM) treatment	upregulated	29781033
272	Human	hsa_circ_0032821	circRNA	oxaliplatin	gastric cancer (GC)	HGC-27 cells; AGS cells	oxaliplatin (OXA) treatment	Circ_0032821 was highly expressed in OXA-resistant GC cells	33123829
273	Human	hsa_circ_0034616	circRNA	5-fluorouracil (5-Fu)	osteosarcoma (OS)	MG63 cells	5-fluorouracil (5-FU) treatment	upregulated	33308021
274	Human	hsa_circ_0035266	circRNA	4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and lipopolysaccharide (LPS)	inflammation	BEAS-2B cells	4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and lipopolysaccharide (LPS) treatment	"We identified a novel circRNA, circ_0035266, which was strongly upregulated in NNK+LPS-induced BEAS-2B cells and enhanced the inflammatory responses to NNK+LPS by regulating the secretion of pro-inflammatory cytokines interleukin (IL)-6 and IL-8."	33107911
275	Human	hsa_circ_0035483	circRNA	gemcitabine (GEM)	renal cell carcinoma (RCC)	renal tissues or TK10 and UO31 cells	gemcitabine treatment	"Hsa_circ_0035483 can facilitate gemcitabine-induced autophagy, and enhance the resistance of RCC to gemcitabine."	31492499
276	Human	hsa_circ_0035944	circRNA	sorafenib (SOR)	hepatocellular carcinoma (HCC)	Huh-7 cells; HepG2 cells	sorafenib treatment	downregulated	32226514
277	Human	hsa_circ_0038467	circRNA	lipopolysaccharide (LPS)	pneumonia	16HBE cells	lipopolysaccharide (LPS) treatment	Circ_0038467 was upregulated and miR-338-3p was downregulated in LPS-treated 16HBE cells.	32181994
278	Human	hsa_circ_0039411	circRNA	neodymium oxide (Nd2O3)	inflammation	human bronchial epithelial cells (16HBE)	neodymium oxide (Nd2O3) treatment	upregulation of circ_0039411 mediated Nd2O3-induced inflammation and dysfunction by sponging miR-93-5p.	30903189
279	Human	hsa_circ_0040768	circRNA	caffeic acid phenethyl ester (CAPE)	cadmium-induced toxicity	HepG2 cells	caffeic acid phenethyl ester (CAPE) treatment	"CAPE significantly (P < 0.05) increased cell viability via inhibiting CdCl2-induced autophagy, and this process was regulated by hsa_circ_0040768/MAP1LC3B axis."	32298858
280	Human	hsa_circ_004077	circRNA	gemcitabine (GEM)	pancreatic cancer (PC)	SWl990 cells	gemcitabine (GEM) treatment	upregulated	29781033
281	Human	hsa_circ_0040824	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	human umbilical vein endothelial cells (HUVECs)	oxidized low-density lipoprotein (ox-LDL) treatment	Our data showed that circ-BANP expression was upregulated in AS blood and ox-LDL-induced HUVECs.	33298736
282	Human	hsa_circ_0041795	circRNA	high glucose (HG)	diabetic retinopathy (DR)	ARPE-19 cells	high glucose (HG) treatment	hsa_circ_0041795 contributes to human retinal pigment epithelial cells (ARPE 19) injury induced by high glucose via sponging miR-646 and activating VEGFC	32259632
283	Human	hsa_circ_0043256	circRNA	cinnamaldehyde (CA)	non-small cell lung cancer (NSCLC)	NCI-H460;A549 cell lines	Cinnamaldehyde (CA) treatment	upregulated	28958934
284	Human	hsa_circ_0043497	circRNA	mycobacterium tuberculosis (Mtb)	tuberculosis (TB)	human monocyte derived macrophages (MDMs)	infect with Mtb	dysregulated	29057952
285	Human	hsa_circ_0044073	circRNA	lipopolysaccharide (LPS)	atherosclerosis (AS)	Human umbilical vein endothelial cells (HUVECs) and human umbilical vein smooth muscle cells (HUVSMCs)	lipopolysaccharide (LPS) treatment	LPS treatment significantly increased the levels of circRNA-0044073 in HUVSMCs but downregulated the levels of circRNA-0044073 in HUVECs. CircRNA-0044073 activates the JAK/STAT signaling pathway of HUVSMCs and HUVECs.	30864721
286	Human	hsa_circ_0044226	circRNA	TGF-¦Â1	idiopathic pulmonary fibrosis (IPF)	The human lung fibroblasts (WI-38 cells)	TGF-¦Â1 treatment	upregulated	31786325
287	Human	hsa_circ_0045462	circRNA	high glucose (HG)	diabetes-associated endothelial dysfunction	human umbilical vein endothelial cells (HUVECs)	?high glucose (HG) induce treatment	dysregulated	31369204
288	Human	hsa_circ_0046366	circRNA	free fatty acids (FFAs; 2:1 oleate:palmitate)	hepatocellular steatosis	HepG2 cells	free fatty acids (FFAs; 2:1 oleate:palmitate) treatment	downregulated	29391755
289	Human	hsa_circ_0047814	circRNA	H2O2	diabetic retinopathy (DR)	ACBRI-183 cells	H2O2 treatment	upregulated	32343678
290	Human	hsa_circ_0047814	circRNA	high glucose (HG)	diabetic retinopathy (DR)	ACBRI-183 cells	high glucose (HG) treatment	upregulated	32343678
291	Human	hsa_circ_0047814	circRNA	IL-6	diabetic retinopathy (DR)	ACBRI-183 cells	IL-6?treatment	upregulated	32343678
292	Human	hsa_circ_0047814	circRNA	tumor necrosis factor alpha (TNF-¦Á) 	diabetic retinopathy (DR)	ACBRI-183 cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	32343678
293	Human	hsa_circ_0047814	circRNA	vascular endothelial growth factor (VEGF)	diabetic retinopathy (DR)	ACBRI-183 cells	VEGF treatment	upregulated	32343678
294	Human	hsa_circ_0054633	circRNA	high glucose (HG)	endothelial dysfunction	human umbilical vein endothelial cells (HUVECs)	high glucose (HG) treatment	upregulated	29693114
295	Human	hsa_circ_0058097	circRNA	excessive mechanical tension	intervertebral disc degeneration (IDD)	primary human endplate chondrocytes culture	Excessive mechanical tension induce	"circRNA_0058097 can upregulate the expression of downstream target gene histone deacetylase 4 by sponge adsorption of miR-365a-5p, which promoted morphological changes of endplate chondrocytes, and increased extracellular matrix degradation and degeneration of endplate cartilage."	31222836
296	Human	hsa_circ_0060060	circRNA	cisplatin (DDP)	anaplastic thyroid carcinoma (ATC)	TPC1 cells; BHT101 cells	cisplatin (DPP) treatment	upregulated	30540564
297	Human	hsa_circ_0060927	circRNA	vitamin D	vitamin D metabolism	HCT-116; HT-29 cells	vitamin D treatment	upregulated	32803502
298	Human	hsa_circ_0061012	circRNA	IL-22	psoriasis	HaCaT cells	IL-22 treatment	Interleukin-22 (IL-22) treatment increased the expression of circ_0061012 in a dose-dependent manner.	33393621
299	Human	hsa_circ_0061052	circRNA	cigarette smoke (CS)	epithelial-mesenchymal transition (EMT)	human bronchial epithelial (HBE) cells	Cigarette smoke (CS) exposure	upregulated	32768781
300	Human	hsa_circ_0063809	circRNA	paclitaxel (PTX)	ovarian cancer (OC)	SKOV3 cells; HeyA-8 cells	paclitaxel (PTX) treatment	The expression of circ_0063809 in PTX-resistant ovarian cancer cells (SKOV3/PTX and HeyA-8/ PTX) was upregulated	31945729
301	Human	hsa_circ_0063809	circRNA	paclitaxel (PTX)	ovarian cancer (OC)	ovarian cancer cells (SKOV3/PTX and HeyA-8/PTX)	paclitaxel (PTX) treatment	"circCELSR1 was highly expressed in PTX-resistant ovarian cancer cell lines, and circCELSR1 silencing enhanced PTX-induced cytotoxicity in ovarian cancer cells"	31945729
302	Human	hsa_circ_0064772	circRNA	high glucose (HG)	diabetes-associated endothelial dysfunction	human umbilical vein endothelial cells (HUVECs)	?high glucose (HG) induce treatment	dysregulated	31369204
303	Human	hsa_circ_006660	circRNA	curcumin (Cur)	nasopharyngeal carcinoma (NPC)	CNE-2R cells	curcumin treatment	upregulated	31793078
304	Human	hsa_circ_0067717	circRNA	hepatitis B virus (HBV)	hepatocellular carcinoma (HCC)	Huh7-HBV;Hep3B-HBV cells	hepatitis B virus (HBV) infection	"Circ-RNF13 was upregulated in HBV-infected human HCC tissues and HBV-expressing cells (Huh7-HBV and Hep3B-HBV), accompanied with TGIF2 upregulation and miR-424-5p downregulated."	33714261
305	Human	hsa_circ_0068087	circRNA	high glucose (HG)	diabetes mellitus (DM)	human umbilical vein endothelial cells (HUVECs)	high glucose (HG) treatment	upregulated	31108165
306	Human	hsa_circ_0068655	circRNA	hypoxia	myocardial infarction (MI)	human induced pluripotent stem-derived cardiomyocytes (HCMs)	hypoxia treatment	Circ_0068655 Promotes Cardiomyocyte Apoptosis via miR-498/PAWR Axis	32767028
307	Human	hsa_circ_0068888	circRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	Human renal proximal tubular cell line HK-2	lipopolysaccharide (LPS) treatment	Decreased hsa_circ_0068888 expression was observed in AKI cell model.	33429194
308	Human	hsa_circ_00699	circRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	cell differentiation	5-aza induced the differentiation of human umbilical cord-derived mesenchymal stem cells (hUCMSCs) into cardiomyocyte-like cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	downregulated	30756390
309	Human	hsa_circ_0073237	circRNA	radiation	glioblastoma multiforme (GBM)	U87 cells; U251 cells	radiation treatment	circ_VCAN expression was significantly downregulated in U87 and U251 cells following irradiation	32080097
310	Human	hsa_circ_0073817	circRNA	5-fluorouracil (5-Fu)	osteosarcoma (OS)	MG63 cells	5-fluorouracil (5-FU) treatment	downregulated	33308021
311	Human	hsa_circ_0076305	circRNA	cisplatin (DDP)	non-small cell lung cancer (NSCLC)	"NSCLC tissues and cells (A549, H1650, A549/DDP, H1650/DDP)"	cisplatin treatment	upregulated	31647948
312	Human	hsa_circ_0076631	circRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	AC16 cells	high glucose treatment	circRNA-0076631 was increased both in high-glucose-treated cardiomyocytes and in the serum of diabetic patients.	31400606
313	Human	hsa_circ_0077930	circRNA	high glucose (HG)	vascular smooth muscle aging	human umbilical vein endothelial cell (HUVEC)	high glucose (HG) treatment	HG-HUVECs derived exosomes induced the VSMCs senescence by circRNA0077930-miR622-Kras CeRNA network.	32307741
314	Human	hsa_circ_007874	circRNA	monastrol	breast cancer	MCF-7 cells; MDA-MB-231 cells	monastrol treatment	circRNA-MTO1 (hsa-circRNA-007874) was validated as a circRNA that exhibited elevated expression levels in monastrol-resistant cells.	30015883
315	Human	hsa_circ_0079662	circRNA	oxaliplatin	colorectal cancer (CRC)	HT29 cells; HCT116 cells; HCT8 cells	oxaliplatin treatment	"hsa_circ_0079662, as a ceRNA binding with hsa-mir-324-5p, can regulate target gene HOXA9 and induced the mechanism of chemotherapy drug oxaliplatin resistance in CRC through the TNF-¦Á pathway in human colon cancer"	32243061
316	Human	hsa_circ_0081001	circRNA	doxorubicin (DOX)	osteosarcoma (OS)	MG63 cells; KHOS cells; U2OS cells	doxorubicin (Dox) treatment	hsa_circ_0081001 was upregulated with 12 fold change in the chemo-resistant OS cell lines.	30263004
317	Human	hsa_circ_0084043	circRNA	high glucose (HG)	diabetic retinopathy (DR)	ARPE-19 cells	high glucose (HG) treatment	Loss of circRNA_0084043 depressed HG-induced damage via sponging miR-140-3p and regulating TGFA.	32259630
318	Human	hsa_circ_0086720	circRNA	radiation	non-small cell lung cancer (NSCLC)	non-small cell lung cancer (NSCLC) tissues	radiation treatment	upregulated	32940043
319	Human	hsa_circ_0088364	circRNA	nitidine chloride (NC)	hepatocellular carcinoma (HCC)	HCC xenograft tumour tissues	Nitidine chloride (NC)?treatment	hsa_circ_0088364 dysregulated.	31506425
320	Human	hsa_circ_008913	circRNA	arsenite	arsenite-induced carcinogenesis	HaCaT cells	arsenite exposure	downregulated	30167605
321	Human	hsa_circ_0090049	circRNA	nitidine chloride (NC)	hepatocellular carcinoma (HCC)	HCC xenograft tumour tissues	Nitidine chloride (NC)?treatment	hsa_circ_0090049 dysregulated.	31506425
322	Human	hsa_circ_0091223	circRNA	¦Á-melanocyte-stimulating hormone (¦Á-MSH)	skin pigmentation disorders	human skin primary melanocytes (MCs)	¦Á-MSH treatment	upregulated	33318297
323	Human	hsa_circ_0092317	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	human THP-1 macrophages	oxidized low-density lipoprotein (ox-LDL) treatment	dysregulated	31804889
324	Human	hsa_circ_0092493	circRNA	hepatitis B virus (HBV)	hepatocellular carcinoma (HCC)	serum	hepatitis B virus (HBV) infection	"?In this study, we performed circRNA microarray profile and found an HBV-related circRNA, circ-ARL3 (hsa_circ_0092493)."	33372396
325	Human	hsa_circ_0096157	circRNA	cisplatin (DDP)	non-small cell lung cancer (NSCLC)	A549 cells	cisplatin treatment	upregulated	32767026
326	Human	hsa_circ_0109320	circRNA	gefitinib	non-small cell lung cancer (NSCLC)	plasma	gefitinib treatment	Elevated hsa_circ_0109320 was associated with longer PFS in gefitinib-treated NSCLC patients. hsa_circ_0109320 may be a potential biomarker for the efficacy of EGFR-TKI in NSCLC patients.	31285870
327	Human	hsa_circ_0110805	circRNA	cisplatin (DDP)	gastric cancer (GC)	AGS cells; HGC-27 cells	cisplatin (DPP) treatment	"circ_0110805 knockdown increased the sensitivity of gastric cancer to cisplatin, which also repressed gastric cancer progression by sponging miR-299-3p to downregulate ENDOPDI expression."	33192077
328	Human	hsa_circ_0113656	circRNA	platelet derived growth factor-BB (PDGF-BB)	vascular restenosis	human aortic vascular smooth muscle cell (HA-VSMC)	platelet derived growth factor-BB (PDGF-BB) treatment	upregulated	32736703
329	Human	hsa_circ_0114427	circRNA	gentamicin	acute kidney injury (AKI)	HK-2 cells	gentamicin treatment	"Circ-0114427 dramatically increased 727 in LPS-, H202-, and gentamicin-induced AKI cell models."	31930399
330	Human	hsa_circ_0114427	circRNA	H2O2	acute kidney injury (AKI)	HK-2 cells	H2O2 treatment	"Circ-0114427 dramatically increased 727 in LPS-, H202-, and gentamicin-induced AKI cell models."	31930399
331	Human	hsa_circ_0114427	circRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	HK-2 cells	LPS treatment	"Circ-0114427 dramatically increased 727 in LPS-, H202-, and gentamicin-induced AKI cell models."	31930399
332	Human	hsa_circ_0114428	circRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	Human renal proximal tubular cell line HK-2	lipopolysaccharide (LPS) treatment	upregulated	33830389
333	Human	hsa_circ_0114876	circRNA	IL-1¦Â	osteoarthritis (OA)	CHON-001 cells	IL-1¦Â treatment	The expression of circ_0114876 was increased in OA tissues and inhibition of circ_0114876 could induce cell viability and suppress inflammation as well as inhibit cell apoptosis in IL-1¦Â induced CHON-001 cells.	33404903
334	Human	hsa_circ_01183	circRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	cell differentiation	5-aza induced the differentiation of human umbilical cord-derived mesenchymal stem cells (hUCMSCs) into cardiomyocyte-like cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	downregulated	30756390
335	Human	hsa_circ_0124644	circRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	human vascular endothelial cells (HUVECs)	oxidized low-density lipoprotein (ox-LDL) treatment	Circular RNA circ_0124644 exacerbates the ox-LDL-induced endothelial injury in human vascular endothelial cells through regulating PAPP-A by acting as a sponge of miR-149-5p.	32500475
336	Human	hsa_circ_0127305	circRNA	1-methyl-4-phenylpyridinium (MPP+)	parkinson's disease (PD)	SH-SY5Y cells	1-methyl-4-phenylpyridinium (MPP+) treatment	upregulated	29953413
337	Human	hsa_circ_0127305	circRNA	pramipexole (PPX)	parkinson's disease (PD)	1-methyl-4-phenylpyridinium (MMP+) treated SH-SY5Y cells	pramipexole (PPX) treatment	downregulated	29953413
338	Human	hsa_circ_0134111	circRNA	IL-1¦Â	osteoarthritis (OA)	human chondrocytes	IL-1¦Â treatment	Circ_0134111 was overexpressed in OA cartilage tissues and IL-1¦Â-induced chondrocytes.	33684877
339	Human	hsa_circ_0134501	circRNA	gefitinib	non-small cell lung cancer (NSCLC)	plasma	gefitinib treatment	dysregulated	31285870
340	Human	hsa_circ_01536	circRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	cell differentiation	5-aza induced the differentiation of human umbilical cord-derived mesenchymal stem cells (hUCMSCs) into cardiomyocyte-like cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	upregulated	30756390
341	Human	hsa_circ_01536	circRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	cell differentiation	5-aza induced the differentiation of human umbilical cord-derived mesenchymal stem cells (hUCMSCs) into cardiomyocyte-like cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	"Network analysis uncovered three potential key circRNAs, that is, circRNA_05432, circRNA_08441, and circRNA_01536."	30756390
342	Human	hsa_circ_01978	circRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	cell differentiation	5-aza induced the differentiation of human umbilical cord-derived mesenchymal stem cells (hUCMSCs) into cardiomyocyte-like cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	downregulated	30756390
343	Human	hsa_circ_04411	circRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	cell differentiation	5-aza induced the differentiation of human umbilical cord-derived mesenchymal stem cells (hUCMSCs) into cardiomyocyte-like cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	upregulated	30756390
344	Human	hsa_circ_05432	circRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	cell differentiation	5-aza induced the differentiation of human umbilical cord-derived mesenchymal stem cells (hUCMSCs) into cardiomyocyte-like cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	"Network analysis uncovered three potential key circRNAs, that is, circRNA_05432, circRNA_08441, and circRNA_01536."	30756390
345	Human	hsa_circ_08441	circRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	cell differentiation	5-aza induced the differentiation of human umbilical cord-derived mesenchymal stem cells (hUCMSCs) into cardiomyocyte-like cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	"Network analysis uncovered three potential key circRNAs, that is, circRNA_05432, circRNA_08441, and circRNA_01536."	30756390
346	Human	hsa_circ_09169	circRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	cell differentiation	5-aza induced the differentiation of human umbilical cord-derived mesenchymal stem cells (hUCMSCs) into cardiomyocyte-like cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	upregulated	30756390
347	Human	hsa_circ_09905	circRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	cell differentiation	5-aza induced the differentiation of human umbilical cord-derived mesenchymal stem cells (hUCMSCs) into cardiomyocyte-like cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	upregulated	30756390
348	Human	hsa_circ_100284	circRNA	arsenite	acceleration of the cell cycle and carcinogenesis	HaCaT cells	arsenic exposure	upregulated	28062277
349	Human	hsa_circ_100284	circRNA	arsenite	bladder cancer	Normal bladder SV-HUC-1 cells	?arsenite treatment	"With prolonged contact time with arsenite, the expression level of circRNA-100284 in cells increased continuously"	33386469
350	Human	hsa_circ_100284	circRNA	arsenite	cell cycle and proliferation	human hepatic epithelial (L-02) cells	arsenite exposure	circRNA_100284 is involved in the malignant transformation of L-02 cells induced by arsenite.	29674685
351	Human	hsa_circ_100338	circRNA	hypoxia/reoxygenation (H/R)	angiogenesis	human umbilical vein endothelial cells (HUVECs)	hypoxia/reoxygenation (H/R) treatment	The expression of circ-100338 was decreased in HUAECs after H/R treatment.	32572929
352	Human	hsa_circ_100797	circRNA	ultraviolet (UV) irradiation	cell senescence	human fibroblast	"the UVB irradiation output was monitored using a Waldmann UV meter (Waldmann, Villigen©\Schwenningen, Germany). UVB dose = UVB irradiance ¡Á time in second (s), with a distance of 15 cm between the lamp and cell culture dish. The UVB with 10 mJ/cm2 was delivered to cells daily for 5 days and at 48 hr after the last irradiation treatment"	circRNA_100797 had a low expression in ultraviolet B stress-induced human fibroblast premature senescence (UVB-SIPS)	30908647
353	Human	hsa_circ_101237	circRNA	cisplatin (DDP)	hepatocellular carcinoma (HCC)	serum of patients; Huh7 cells	cisplatin treatment	upregulated	32226487
354	Human	hsa_circ_101237	circRNA	bortezomib	multiple myeloma (MM)	MM.1S cells; H929 cells	bortezomib? treatment	upregulated	32256118
355	Human	hsa_circ_101505	circRNA	cisplatin (DDP)	hepatocellular carcinoma (HCC)	The cisplatin-resistant Hep3B (Hep3B-R) and Huh7 (Huh7-R) cells	cisplatin treatment	"Gain-of-function investigations showed that overexpression of circRNA_101505 suppressed cancer cell growth in vivo and in vitro, and enhanced cisplatin toxicity in HCC cells."	31372241
356	Human	hsa_circ_101543	circRNA	gemcitabine (GEM)	pancreatic cancer (PC)	SWl990 cells	gemcitabine (GEM) treatment	downregulated	29781033
357	Human	hsa_circ_101672	circRNA	gemcitabine (GEM)	pancreatic cancer (PC)	SWl990 cells	gemcitabine (GEM) treatment	upregulated	29781033
358	Human	hsa_circ_102115	circRNA	curcumin (Cur)	nasopharyngeal carcinoma (NPC)	CNE-2 cells	curcumin treatment	"circ_102115 was upregulated in CNE-2 cells after treatment by radiation, while curcumin treatment downregulated the expression."	32127962
359	Human	hsa_circ_102610	circRNA	TGF-¦Â1	crohn disease (CD)	human intestinal epithelial cells (HIECs); normal-derived colon mucosa cell line 460 (NCM460) cells	TGF-¦Â1 treatment	Hsa_circRNA_102610 upregulation in CD patients could promote the proliferation and EMT of intestinal epithelial cells via sponging of hsa-miR-130a-3p	32587447
360	Human	hsa_circ_102747	circRNA	gemcitabine (GEM)	pancreatic cancer (PC)	SWl990 cells	gemcitabine (GEM) treatment	downregulated	29781033
361	Human	hsa_circ_103572	circRNA	curcumin (Cur)	nasopharyngeal carcinoma (NPC)	CNE-2 cells	curcumin treatment	"circ_103572 was downregulated in CNE-2 cells after treatment by radiation, while curcumin treatment upregulated the expression."	32127962
362	Human	hsa_circ_103765	circRNA	tumor necrosis factor alpha (TNF-¦Á) 	crohn disease (CD)	Caco2 and HIEC cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	33436852
363	Human	hsa_circ_103809	circRNA	cisplatin (DDP)	non-small cell lung cancer (NSCLC)	A549 cells; H1299 cells	cisplatin treatment	upregulated	33276753
364	Human	hsa_circ_104057	circRNA	curcumin (Cur)	nasopharyngeal carcinoma (NPC)	CNE-2 cells	curcumin treatment	"circ_104057 was downregulated in CNE-2 cells after treatment by radiation, while curcumin treatment upregulated the expression."	32127962
365	Human	hsa_circ_104075	circRNA	matrine	glioblastoma multiforme (GBM)	Glioma cell line U251?cells	Matrine treatment	Matrine decreased circRNA-104075 expression significantly. Overexpression of circRNA-104075 was found to counteract the inhibitory effects of matrine on cell proliferation and promoting effects on apoptosis and autophagy in U251?cells.	31112718
366	Human	hsa_circ_104250	circRNA	particulate matter (PM2.5)	airway inflammation	"human bronchial epithelial cell line, BEAS-2B"	particulate matter 2.5 (PM2.5) exosure treatment	upregulated	31864925
367	Human	hsa_circ_104250	circRNA	particulate matter (PM2.5)	airway inflammation	"human bronchial epithelial cell line, BEAS-2B"	particulate matter 2.5 (PM2.5) exposure treatment	upregulated	31864925
368	Human	hsa_circ_104883	circRNA	curcumin (Cur)	nasopharyngeal carcinoma (NPC)	CNE-2R cells	curcumin treatment	downregulated	31793078
369	Human	hsa_circ_13360	circRNA	platelet derived growth factor-BB (PDGF-BB)	atherosclerosis (AS)	primary human aortic smooth muscle cells (HASMCs)	platelet-derived growth factor (PDGF)-BB treatment	upregulated	32547599
370	Human	hsa_circ_14411	circRNA	platelet derived growth factor-BB (PDGF-BB)	atherosclerosis (AS)	primary human aortic smooth muscle cells (HASMCs)	platelet-derived growth factor (PDGF)-BB treatment	upregulated	32547599
371	Human	hsa_circ_16804	circRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	cell differentiation	5-aza induced the differentiation of human umbilical cord-derived mesenchymal stem cells (hUCMSCs) into cardiomyocyte-like cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	downregulated	30756390
372	Human	hsa_circ_1698	circRNA	platelet derived growth factor-BB (PDGF-BB)	atherosclerosis (AS)	primary human aortic smooth muscle cells (HASMCs)	platelet-derived growth factor (PDGF)-BB treatment	upregulated	32547599
373	Human	hsa_circ_1848	circRNA	platelet derived growth factor-BB (PDGF-BB)	atherosclerosis (AS)	primary human aortic smooth muscle cells (HASMCs)	platelet-derived growth factor (PDGF)-BB treatment	downregulated	32547599
374	Human	hsa_circ_2858	circRNA	escherichia coli (E.coli)	meningitis	human brain microvascular endothelial cells (hBMECs)	escherichia coli (E. coli) infection	circ_2858 was upregulated in human brain microvascular endothelial cells (hBMECs) upon meningitic E. coli infection.	33230468
375	Human	hsa_circ_3041	circRNA	platelet derived growth factor-BB (PDGF-BB)	atherosclerosis (AS)	primary human aortic smooth muscle cells (HASMCs)	platelet-derived growth factor (PDGF)-BB treatment	downregulated	32547599
376	Human	hsa_circ_3046	circRNA	herpes simplex virus 1 (HSV-1)	herpes simplex virus 1 (HSV-1) infection	KMB17 cells	herpes simplex virus 1 (HSV-1) treatment	upregulated	29972822
377	Human	hsa_circ_3140	circRNA	mechanical force (MF)	osteogenesis	human periodontal ligament stem cells (PDLSCs)	mechanical force (MF)?induce	"circRNA3140 was highly and widely associated with microRNA-21, which plays a critical role in MF-induced osteogenic differentiation of PDLSCs."	30422310
378	Human	hsa_circ_33287	circRNA	bone morphogenetic protein 2 (BMP2)	cell differentiation	maxillary sinus membrane stem cells (MSMSCs)	bone morphogenetic protein 2 (BMP2) treatment	Hsa_circRNA_33287 promotes the osteogenic differentiation of maxillary sinus membrane stem cells via miR-214-3p/Runx3.	30551425
379	Human	hsa_circ_3875	circRNA	platelet derived growth factor-BB (PDGF-BB)	atherosclerosis (AS)	primary human aortic smooth muscle cells (HASMCs)	platelet-derived growth factor (PDGF)-BB treatment	downregulated	32547599
380	Human	hsa_circ_402801	circRNA	curcumin (Cur)	nasopharyngeal carcinoma (NPC)	CNE-2 cells	curcumin treatment	"circ_402801 was upregulated in CNE-2 cells after treatment by radiation, while curcumin treatment downregulated the expression."	32127962
381	Human	hsa_circ_403658	circRNA	hypoxia	bladder cancer	hypoxia-induced 5637;T24 cells	hypoxia-induce	"hsa-circ_403658 was an important circRNA that upregulated in bladder cancer cells under hypoxia, and higher hsa-circ_403658 levels were associated with poorer survival outcome."	31814891
382	Human	hsa_circ_406961	circRNA	particulate matter (PM2.5)	airway inflammation	BEAS-2B cells	Fine particulate matter (PM2.5) treatment	"circ_406961 inhibited activation of STAT3/JNK pathways via interacting with ILF2 protein, thereby inhibiting the PM25-induced inflammatory reaction"	32388272
383	Human	hsa_circ_4099	circRNA	H2O2	hepatitis	L02 cells	H2O2 treatment	circRNA-4099 was stimulated by H2O2. Plentiful circRNA-4099 augmented H2O2-resulted damage.	31479678
384	Human	hsa_circ_4099	circRNA	H2O2	hepatitis	L02 cells	H2O2 treatment	upregulated	31479678
385	Human	hsa_circ_4099	circRNA	tumor necrosis factor alpha (TNF-¦Á) 	intervertebral disc degeneration (IDD)	NP cells	tumor necrosis factor alpha (TNF-¦Á) treatment	TNF-¦Á treatment increased circ-4099 expression in NP cells	29651107
386	Human	hsa_circ_4452	circRNA	platelet derived growth factor-BB (PDGF-BB)	atherosclerosis (AS)	primary human aortic smooth muscle cells (HASMCs)	platelet-derived growth factor (PDGF)-BB treatment	upregulated	32547599
387	Human	hsa_circ_51217	circRNA	R-2-hydroxyglutarate (R-2HG)	prostate cancer	"C4-2, PC3, DU145, LNCaP cells"	R-2-hydroxyglutarate (R-2HG) treatment	upregulated	31846689
388	Human	hsa_circ_5780	circRNA	platelet derived growth factor-BB (PDGF-BB)	atherosclerosis (AS)	primary human aortic smooth muscle cells (HASMCs)	platelet-derived growth factor (PDGF)-BB treatment	downregulated	32547599
389	Human	hsa_circ_6783	circRNA	herpes simplex virus 1 (HSV-1)	herpes simplex virus 1 (HSV-1) infection	KMB17 cells	herpes simplex virus 1 (HSV-1) treatment	upregulated	29972822
390	Human	hsa_circ_859267	circRNA	ultraviolet (UV) irradiation	photoaging	human dermal fibroblasts (HDFs)	UVA irradiated treatment	downregulated	28286269
391	Human	hsa_circ_8979	circRNA	platelet derived growth factor-BB (PDGF-BB)	atherosclerosis (AS)	primary human aortic smooth muscle cells (HASMCs)	platelet-derived growth factor (PDGF)-BB treatment	upregulated	32547599
392	Human	hsa_circ_9119	circRNA	polyinosinic-polycytidilic acid (Poly(I:C))	orchitis	testicular cells	poly I:C treatment	upregulated	31195953
393	Human	hsa_circ_9119	circRNA	IL-1¦Â	osteoarthritis (OA)	SW1353 cells	IL-1¦Â treatment	downregulated	32522568
